跳至主要内容
临床试验/TCTR20161010005
TCTR20161010005招募中3 期

A study of retinal microvascular changes in Diabetic Macular Edema using the swept †source optical coherence tomography angiography (OCTA) after being treated with Anti-Vascular endothelial growth factors (Anti-VEGF)

Ratchadapiseksompot Endowment Fund0 个研究点目标入组 40 人开始时间: 2016年10月10日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • - Patients diagnosed with Diabetic Macular Edema (DME).
  • - Age > 18 years of age who have signed an inform consent.
  • - Candidates to be treated with Intravitreous Anti-VEGF ( Aflibercept , Bevacizumab and Ranibizumab )
  • - No history of Anti-VEGF treatment within 3 months.
  • - No history of retina surgery.

排除标准

  • - Presence of severe media opacities.
  • - Patients who have other disease: monoculus, eye injuries , glaucoma, uveitis, retinal vein occlusion, retinal arterial occlusion, hereditary and degenerative macular disease, retinal and choroidal detachment.
  • - Any previous treatment for DME e.g. Focal / Grid LASER , IVT steroid injection/implant with in 6 months.

研究者

发起方
Ratchadapiseksompot Endowment Fund

相似试验

A study of retinal microvascular changes in Diabetic... | 临床试验